Turing Refuses To Lower Cost Of Daraprim, Hides News Ahead Of Thanksgiving Holiday
from the the-absolute-worst dept
When last we checked in with Martin Shkreli -- founder of Turing Pharmaceuticals and the personification of everything that's wrong with the pharmaceutical industry and mankind -- he was feebly defending his company's decision to jack up the price of a 60-year-old medication some 5000%. Shkreli became America's least liked human being after his company increased the price per pill of Daraprim (used by both AIDS and cancer patients) from $13.50 per pill to $750 per pill. After relentless criticism, Shkreli appeared to backpedal, claiming last September the company would lower prices:"We’ve agreed to lower the price on Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit,” he told ABC News. “We think these changes will be welcomed."Yeah, or not.
Hoping to bury any criticism ahead of the Thanksgiving holiday, Turing released a dodgy press release on Wednesday implying the company had finally seen the error of its ways and would be reducing the cost of Daraprim. Except it's not actually doing anything of the sort. While the company will offer hospitals a 50% discount (now only a 2500% mark up) and is engaging in a few superficial efforts most companies already offer via their patient assistance programs, the press release buries the lede in that the core price of Daraprim isn't going anywhere.
And, just to add insult to injury, a company spokesman insists that's a good thing because (I kid you not) lower drug prices don't benefit patients:
"Drug pricing is one of the most complex parts of the healthcare industry. A drug's list price is not the primary factor in determining patient affordability and access. A reduction in Daraprim's list price would not translate into a benefit for patients."There's nothing complex about being a raging asshole. There's also nothing complex about a former hedge fund manager jacking up the price of an essential drug 5000% (as is happening with many previously-inexpensive generics), pretending he'd seen the error of his ways, then feebly trying to hide his total lack of integrity ahead of a long holiday weekend.
Thank you for reading this Techdirt post. With so many things competing for everyone’s attention these days, we really appreciate you giving us your time. We work hard every day to put quality content out there for our community.
Techdirt is one of the few remaining truly independent media outlets. We do not have a giant corporation behind us, and we rely heavily on our community to support us, in an age when advertisers are increasingly uninterested in sponsoring small, independent sites — especially a site like ours that is unwilling to pull punches in its reporting and analysis.
While other websites have resorted to paywalls, registration requirements, and increasingly annoying/intrusive advertising, we have always kept Techdirt open and available to anyone. But in order to continue doing so, we need your support. We offer a variety of ways for our readers to support us, from direct donations to special subscriptions and cool merchandise — and every little bit helps. Thank you.
–The Techdirt Team
Filed Under: daraprim, drug pricing, drugs, martin shkreli, pharmaceuticals
Companies: turing pharmaceutical
Reader Comments
Subscribe: RSS
View by: Time | Thread
This is not especially sophisticated, no.
[ link to this | view in chronology ]
Re:
[ link to this | view in chronology ]
[ link to this | view in chronology ]
[ link to this | view in chronology ]
[ link to this | view in chronology ]
Re:
However, the guy here seems to imply that the "marketing" and "conflicting of interests" are far more significant for pricing today than any other costs. That he is saying such is very disturbing since it points to a market that doesn't appear anything near healthy.
[ link to this | view in chronology ]
Re: Re:
It's a myth, like fairies and unicorns. Think about it: if you're in a position to wall off your land and charge rent to walk through it, will you do that to make a buck or let people ramble around it at will?
That is the problem with patents or IPR of any kind; that's what it's for. That is why allowing such monopolies to exist on necessities like drugs is immoral. The market won't correct itself. That there's an alternative doesn't matter that much; the failure to shift the price of the drug downwards means it's not that much of an alternative and we're stuck in a market lockdown situation.
I can understand wanting a monopoly on the distribution of a song, a book, or a movie, and as much as access to culture to use and remix as we see fit is important, it's not a life-affecting essential. Medicine is. Shkreli has made the case for getting IPR off medicines and medical equipment and the sooner this is done, the better.
We can work at prying healthcare out of the clutches of the insurance giants afterwards.
[ link to this | view in chronology ]
Proof
May his knees be broken repeatedly henceforth by a rabid badger with a spikey ballbat.
[ link to this | view in chronology ]
Re: Proof
I strongly suggest that you offer a non-rabid badger and ballbat without spikes under certain narrow circumstances. Be sure to point out that non-threatening and non-violent responses don't benefit those like Shkreli.
[ link to this | view in chronology ]
Re: Proof
[ link to this | view in chronology ]
[ link to this | view in chronology ]
Re: Still laughing
[ link to this | view in chronology ]
http://www.pharmamanufacturing.com/industrynews/2015/competitor-turings-daraprim/
[ link to this | view in chronology ]
You missed his point..
Health care hasn't given a rodent's hind quarters about patient affordability in years...
And don't forget - there is minimal short-term profit in a cure - but maximum long-term profit in treatments...
[ link to this | view in chronology ]
Re: You missed his point..
https://www.youtube.com/watch?v=G7P4iFg048k
[ link to this | view in chronology ]
http://s2.quickmeme.com/img/30/30e9ff94b835cd2aaeb03b7d1179362c0abdd4e46e1717132ab1e96fba25388 6.jpg
[ link to this | view in chronology ]
Re:
imgur.com/kUG4C9b
[ link to this | view in chronology ]
[ link to this | view in chronology ]
[ link to this | view in chronology ]
[ link to this | view in chronology ]
[ link to this | view in chronology ]
Re:
[ link to this | view in chronology ]
this is how you get private jets and huge yachts
he will get to the point where he HAS TO hire a PR firm and declare himself a philanthropist
like Rockefeller, Carnegie, Bill Gates, Warren Buffet, etc
[ link to this | view in chronology ]
Re:
http://www.zerohedge.com/news/2015-11-26/martin-shrekli-sets-out-crush-kalobios-shorts-will- stop-lending-out-shares
nothing wrong about that, either
[ link to this | view in chronology ]
[ link to this | view in chronology ]
almost worth buying a horse for
So a quick Googling found quart-sized bottles (intended for horses) for under $100. Another sad example of the usual ten-thousand-percent+ markup whenever a common veterinary drug is packaged and sold for human use.
[ link to this | view in chronology ]
[ link to this | view in chronology ]
https://en.wikipedia.org/wiki/Pyrimethamine#Availability_and_price
[ link to this | view in chronology ]
Re:
what kind of a government would ban the import of such a medicine?
[ link to this | view in chronology ]
Re: Re:
[ link to this | view in chronology ]
Re: Re: Re:
[ link to this | view in chronology ]
This is your fault
[ link to this | view in chronology ]